Kezar Life Sciences | PRE 14A: Preliminary proxy statements relating to merger or acquisition
Apr 16 16:22 ET
Kezar Life Sciences | 424B5: Prospectus
Mar 22 16:11 ET
Kezar Life Sciences | S-8: Initial registration statement for securities to be offered to employees pursuant to employee benefit plans
Mar 14 16:36 ET
Kezar Life Sciences | 10-K: Annual report
Mar 14 16:22 ET
Kezar Life Sciences | 8-K: Kezar Life Sciences Reports Fourth Quarter and Year End 2023 Financial Results and Provides Business Update
Mar 14 16:08 ET
Kezar Life Sciences | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-OrbiMed Capital LLC(2.7%),OrbiMed Advisors LLC(0.0%)
Feb 14 18:53 ET
Kezar Life Sciences | SC 13G: Statement of acquisition of beneficial ownership by individuals-Barclays PLC(5.27%),Barclays Bank PLC(5.27%), etc.
Feb 14 18:48 ET
Kezar Life Sciences | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Avidity Partners Management LP(6.9%),Avidity Partners Management (GP) LLC(6.9%), etc.
Feb 14 06:51 ET
Kezar Life Sciences | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Suvretta Capital Management, LLC(9.9%),Aaron Cowen(9.9%), etc.
Feb 13 12:00 ET
Kezar Life Sciences | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Prosight Management, LP(4.6%),Prosight Partners, LLC(4.6%), etc.
Feb 13 09:54 ET
Kezar Life Sciences | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-BlackRock, Inc.(6.6%)
Jan 29 15:33 ET
Kezar Life Sciences | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-STATE STREET CORPORATION(1.54%)
Jan 23 00:00 ET
Kezar Life Sciences | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Millennium Management LLC(4.0%),Millennium Group Management LLC(4.0%), etc.
Jan 22 00:00 ET
Kezar Life Sciences | 3: Initial statement of beneficial ownership of securities-Officer Schiller Mark C.
Jan 17 00:00 ET
Kezar Life Sciences | 4: Statement of changes in beneficial ownership of securities-Officer Belsky Marc
Jan 9 00:00 ET
Kezar Life Sciences | 4: Statement of changes in beneficial ownership of securities-Officer Mordwinkin Nicholas Michael
Jan 9 00:00 ET
Kezar Life Sciences | 8-K: Current report
Jan 8 00:00 ET
Kezar Life Sciences | 8-K: Current report
Dec 4, 2023 16:28 ET
Kezar Life Sciences: Q3 2023 Earnings Report
Nov 13, 2023 16:13 ET
Kezar Life Sciences | 8-K: Kezar Life Sciences Reports Third Quarter 2023 Financial Results and Provides Business Update
Nov 13, 2023 16:05 ET
No Data
No Data